论文部分内容阅读
复治菌阳病人在无条件取得药敏试验情况下,采取何种化疗方案和管理措施,方能提高疗效,控制传染,这是本文探讨的主要目的。本文58例,系1979年流调查出,并经18个月以上标化治疗失败的涂阳病人,年龄11～73岁,平均50.9岁。最短病程1.5年,最长18年,平均5.6年。Ⅲ型40例(69％),Ⅳ型18例(31％)。病变占四个肺野以上者41例(70.7％),具明显空洞者55例(95％)。排菌(++)以上者40例(69％)。既往用药:平均H两年八个月,
In the condition of unconditional access to drug susceptibility test, what kind of chemotherapy regimen and management measures should be taken in patients with retreatment bacilli to improve the curative effect and control the infection? This is the main purpose of this paper. 58 cases of this article, the flow was identified in 1979, and after 18 months of standardization failed to cure smear positive patients, aged 11 to 73 years, mean 50.9 years old. Shortest duration of 1.5 years, up to 18 years, an average of 5.6 years. 40 cases were type Ⅲ (69%), 18 cases were type Ⅳ (31%). Thirty-one patients (70.7%) were diagnosed as having lung disease or more in four lesions, and 55 (95%) had obvious vacuolization. Excretion (++) more than 40 cases (69%). Past medication: the average H two years and eight months,